Skip to main content

Strategic Blueprint, LLC

Position in LLY — ELI LILLY & Co

CIK 1767821 ATLANTA, GA

Position in LLY

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$16,427,394
+$5,145,496 QoQ
Shares Held
13,696
+11.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.10%
of 13F equity value
Holder Rank
#990
of 4,621 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Jun 30, 2025
CallValue
$935,436
CallShares
1,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Strategic Blueprint, LLC holds $25,782,970 across 8 Drug Manufacturers - General names. LLY ranks #1 (63.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page
13,696 $16,427,394

All Filings in LLY

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,427,394 13,696
2026-03-31 $11,281,898 12,266
2025-12-31 $13,048,765 12,142
2025-09-30 $10,853,675 14,225
2025-06-30 $11,174,562 14,335
2025-06-30 $935,436 1,200
2025-03-31 $10,612,943 12,850
2024-12-31 $8,913,512 11,546
2024-09-30 $10,244,124 11,563
2024-06-30 $10,888,099 12,026
2024-03-31 $9,457,659 12,157
2023-12-31 $7,111,624 12,200
2023-09-30 $6,505,181 12,111
2023-06-30 $5,806,910 12,382
2023-03-31 $1,812,914 5,279
2022-12-31 $1,720,545 4,703
2022-09-30 $32,335 100
2022-09-30 $1,689,827 5,226
2022-06-30 $1,677,241 5,173
2022-03-31 $1,302,410 4,548
2021-12-31 $1,189,955 4,308
2021-09-30 $692,225 2,996
2021-06-30 $657,574 2,865
2021-03-31 $493,204 2,640
2020-12-31 $487,103 2,885
2020-09-30 $384,555 2,598
2020-06-30 $337,061 2,053